Next generation gene based therapeutics for cancer treatment and immune modulation
Recent advances in molecular biology, genetic engineering, and biotechnology have accelerated the development of next-generation gene-based therapeutic platforms in oncology. Despite substantial progress in conventional and targeted treatments, limited response durability, therapeutic resistance, and tumor heterogeneity continue to drive the need for more precise, programmable, and personalized therapeutic strategies. In this review, prominent current gene-based therapeutic approaches in the field of cancer treatment and immune modulation have been comprehensively evaluated. In particular, the potential of CRISPR/Cas-based genome editing technologies, RNA-based biotechnological platforms, mRNA and RNA interference (RNAi)-based therapies, and genetically modified immune cell approaches in cancer treatment has been discussed. In addition, the roles of CAR-T and CAR-NK cell engineering, macrophage reprogramming strategies and RNA-mediated immune reprogramming approaches in regulating the tumour microenvironment and enhancing the anti-tumour immune response have been examined. The combination of gene editing technologies, RNA biotechnologies and immune cell engineering is making significant contributions to the development of more targeted, effective and personalised approaches to cancer treatment. Unlike previous reviews that primarily discuss these technologies separately, this review provides a critical comparative evaluation of genome editing, RNA-based therapeutics and engineered immune-cell platforms with respect to their mechanisms, clinical maturity, delivery strategies, safety profiles and translational potential. This integrated perspective highlights complementary therapeutic opportunities and identifies current challenges that must be addressed for the successful implementation of precision oncology.
Authors
- Harika Topal Önal (ORCID: https://orcid.org/0000-0002-7466-2942)
Institutions
- Toros University (TR)
Publication Details
- Journal
- Discover Biotechnology
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1007/s44340-026-00066-x
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00